Safety of Multiple Sclerosis Treatments During Pregnancy: An Overview of the EU Regulatory Approach to Risk Management Planning.
- DOI
- 10.1002/pds.70506
- Published
- 2026 Nov
- Container
- Pharmacoepidemiology and drug safety
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/pds.70506,
title = {Safety of Multiple Sclerosis Treatments During Pregnancy: An Overview of the EU Regulatory Approach to Risk Management Planning.},
author = {Strassmann V and Gault N and Stark AK and Vaillant T and Berbain T and Martirosyan L and Sarinic VM and Nordeng HME},
year = {2026},
journal = {Pharmacoepidemiology and drug safety},
doi = {10.1002/pds.70506},
url = {https://doi.org/10.1002/pds.70506}
}RIS
TY - JOUR TI - Safety of Multiple Sclerosis Treatments During Pregnancy: An Overview of the EU Regulatory Approach to Risk Management Planning. AU - Strassmann V AU - Gault N AU - Stark AK AU - Vaillant T AU - Berbain T AU - Martirosyan L AU - Sarinic VM AU - Nordeng HME PY - 2026 JO - Pharmacoepidemiology and drug safety DO - 10.1002/pds.70506 UR - https://doi.org/10.1002/pds.70506 ER -
APA
V, S., N, G., AK, S., T, V., T, B., L, M., VM, S., & HME, N. (2026). Safety of Multiple Sclerosis Treatments During Pregnancy: An Overview of the EU Regulatory Approach to Risk Management Planning.. Pharmacoepidemiology and drug safety. https://doi.org/10.1002/pds.70506
Source records
- pubmed · retrieved 2026-11-10T10:11:32.348Z